ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,287 | -99.5% | 13,743 | +609.9% | 0.01% | +300.0% |
| Q2 2021 | $255,000 | -33.6% | 1,936 | -34.9% | 0.00% | -50.0% |
| Q1 2021 | $384,000 | +74.5% | 2,976 | +125.6% | 0.01% | +200.0% |
| Q4 2020 | $220,000 | -83.1% | 1,319 | -90.2% | 0.00% | -95.6% |
| Q3 2019 | $1,299,000 | -61.7% | 13,482 | -54.3% | 0.04% | -66.7% |
| Q2 2019 | $3,396,000 | -32.8% | 29,491 | -31.3% | 0.14% | -64.2% |
| Q1 2019 | $5,056,000 | – | 42,954 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |